No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
244 |
4. Check minimum number of eventsNone |
244 |
5. Include endpointsNone |
244 |
6. Filter based on genotype QC (FinnGen only) |
244 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neurofibromatosis, type 1
based on the number of shared cases.
Similar with more cases:
- Phakomatoses, not elsewhere classified
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 244 | 149 | 95 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 36.12 | 36.50 | 35.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
16
18
9.44
13.03
3.3
2.5
nmol/l
2.2
3.0
0.34
16
18
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
25
7.23
11.16
2.5
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
22
7.20
9.85
2.2
1.4
nmol/l
—
—
—
0
0
(3002256) Pathology report gross observation
53
224
2.75
8.78
1.6
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
42
163
2.90
8.13
7.0
12.4
mmol/l
-0.5
1.1
1.32
27
127
(40768804) Tissue Pathology biopsy report
117
737
2.13
7.67
2.6
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
119
758
2.11
7.55
7.3
6.7
mmol/l
1.2
1.2
2.94
112
697
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
33
121
3.00
7.03
7.6
7.1
mmol/l
23.1
24.9
3.05
33
121
(4035726)
39
157
2.77
7.03
1.3
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
122
822
1.97
6.28
8.3
7.4
mmol/l
1.2
1.2
1.50
102
712
(3032080) INR in Blood by Coagulation assay
94
602
1.91
5.44
4.2
6.3
inr
1.1
1.1
0.08
32
180
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
23
4.96
5.06
1.8
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
86
576
1.76
4.10
2.3
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
41
216
2.08
4.04
2.0
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
59
359
1.85
3.83
2.0
2.4
e6/l
6.3
6.2
0.03
54
316
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
39
3.46
3.82
2.2
1.7
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
6
10.21
3.51
5.2
3.3
nmol/l
64.2
41.2
—
6
6
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
32
3.55
3.37
1.8
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
84
2.50
3.32
6.2
17.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
11
33
3.44
3.23
3.8
3.2
mmol/l
1.1
3.1
—
5
23
(3013290) Carbon dioxide [Partial pressure] in Blood
11
33
3.44
3.23
3.8
3.2
kpa
4.7
5.1
1.07
11
33
(3027315) Oxygen [Partial pressure] in Blood
11
33
3.44
3.23
3.8
3.2
kpa
9.3
8.9
0.42
11
33
(3029937) Albumin [Presence] in Urine by Test strip
71
478
1.68
3.22
3.8
3.4
estimate
0.0
0.0
0.80
21
175
(3000991) Gas panel - Venous blood
28
140
2.13
3.15
8.6
10.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
90
651
1.61
3.05
3.7
3.3
e6/l
30.6
44.2
0.45
74
428
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
88
2.39
3.03
12.0
12.8
%
1.2
1.6
0.88
20
88
(3030467) Casts [#/volume] in Urine by Automated count
72
496
1.64
2.96
2.7
2.7
e6/l
0.8
0.4
0.35
62
357
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
620
1.60
2.94
3.2
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
73
506
1.63
2.93
5.5
3.4
ph
7.4
7.4
0.72
19
85
(3019060) Gas panel - Arterial blood
20
91
2.30
2.82
5.1
10.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
76
540
1.59
2.73
2.8
2.8
e6/l
35.2
153.9
0.47
66
404
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
24
3.85
2.70
1.7
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
19
87
2.28
2.65
12.6
13.1
%
0.6
0.7
0.28
19
87
(3018677) aPTT in Platelet poor plasma by Coagulation assay
41
250
1.77
2.62
2.1
2.2
s
29.4
29.8
0.25
41
242
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
38
2.98
2.61
5.7
3.4
%
58.0
56.7
0.09
11
38
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
15
4.77
2.61
1.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
345
0.45
2.61
1.4
1.2
u/ml
1.1
6.5
—
5
136
(3042936) Bacteria identified in Isolate by Culture
40
243
1.77
2.58
2.3
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
138
1617
0.66
2.53
3.3
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
89
2.23
2.52
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
124
2.04
2.50
2.7
2.5
ml/min/173m2
77.3
72.0
—
8
53
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
154
1.92
2.46
4.0
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
70
499
1.56
2.46
2.6
2.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
421
1.60
2.45
4.3
3.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
40
2.83
2.41
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
11
40
2.83
2.41
4.0
3.0
ph
7.4
7.4
0.10
11
33
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
109
862
1.48
2.33
4.4
4.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
19
3.76
2.16
1.9
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
49
334
1.58
2.06
2.4
2.5
mosm/kgh2o
648.5
566.0
1.05
44
286
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
38
2.70
2.03
1.5
2.9
e9/l
3.9
4.5
—
10
38
(3035637) Corticotropin [Mass/volume] in Plasma
8
26
3.15
2.03
2.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
77
587
1.46
1.92
2.7
3.1
ng/l
22.4
23.7
0.08
44
343
(3024561) Albumin [Mass/volume] in Serum or Plasma
89
699
1.43
1.89
4.4
4.9
g/l
34.7
36.7
2.41
80
660
(3020891) Body temperature
13
59
2.27
1.87
6.8
5.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
30
185
1.71
1.86
12.2
7.3
mmol/l
106.2
104.4
1.14
30
180
(3000494) Fungus identified in Specimen by Culture
33
209
1.67
1.86
1.9
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
154
1.77
1.85
5.6
4.3
mmol/l
1.2
2.1
0.64
17
119
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
114
939
1.40
1.84
6.8
6.1
umol/l
10.9
11.9
0.38
107
892
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
12
4.23
1.83
1.2
1.6
ug/l
16.2
18.3
—
5
12
(3021601) Nitrite [Presence] in Urine by Test strip
114
943
1.39
1.78
5.0
4.3
estimate
0.0
0.0
0.50
23
176
(3012544) pH of Venous blood
26
156
1.75
1.78
5.6
4.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.97
1.73
1.9
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
105
1.88
1.68
1.6
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
299
1.53
1.67
2.5
2.3
e6/l
1.3
0.7
0.39
24
158
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
175
0.44
1.65
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
70
2.06
1.62
1.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
14
3.62
1.62
1.6
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
50
2.26
1.59
1.7
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
114
956
1.36
1.58
3.7
3.1
estimate
0.0
0.0
0.00
24
165
(3035350) Ketones [Presence] in Urine by Test strip
113
947
1.36
1.57
3.8
3.1
estimate
0.0
0.0
0.00
19
177
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
272
1.52
1.50
2.6
2.5
e6/l
4.7
2.4
0.92
22
132
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
189
1.61
1.48
1.7
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
211
1968
1.53
1.48
17.7
12.6
mmol/l
139.3
139.7
1.29
204
1906
(3023368) Bacteria identified in Blood by Culture
55
413
1.43
1.46
4.8
4.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
22
2.77
1.44
1.2
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
247
0.54
1.44
2.0
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
123
0.39
1.41
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
352
0.62
1.40
1.3
1.3
iu/ml
11.2
29.3
—
5
119
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
70
553
1.37
1.39
2.4
2.6
u/l
48.4
56.7
2.08
61
520
(3023103) Potassium [Moles/volume] in Serum or Plasma
211
1975
1.51
1.38
17.7
12.6
mmol/l
3.9
3.9
0.03
204
1909
(3015377) Calcium [Moles/volume] in Serum or Plasma
72
575
1.36
1.33
3.1
3.4
mmol/l
2.4
2.4
0.28
65
511
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
55
422
1.39
1.30
2.1
2.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
11
55
2.05
1.29
6.7
5.8
mg/l
1.2
1.3
0.61
11
49
(3042631) Mycobacterium sp identified in Specimen
5
18
2.81
1.29
2.0
3.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
27
391
0.65
1.29
1.9
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
25
2.43
1.25
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
49
2.09
1.24
1.8
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
144
1280
1.30
1.23
3.5
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
554
0.71
1.23
2.0
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
421
0.67
1.23
2.1
2.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
19
2.66
1.22
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
128
0.46
1.20
2.7
2.5
e9/l
6.9
4.1
—
6
107
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
87
726
1.31
1.18
3.7
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
147
1315
1.30
1.17
4.5
3.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
20
300
0.64
1.12
1.4
2.3
ug/g
76.0
118.3
0.64
14
240
(40758558) Short blood count panel - Blood
61
491
1.32
1.06
5.3
6.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
189
1.48
1.04
1.7
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
34
2.09
1.03
2.1
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
34
2.09
1.03
2.0
2.6
mmol/l
26.6
25.0
—
7
29
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
108
1.62
0.99
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
23
2.20
0.98
1.2
1.3
—
—
—
0
0
(3013512) EKG study
54
432
1.32
0.98
2.6
3.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
194
1.44
0.93
7.3
6.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
160
1.48
0.93
2.9
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
28
2.17
0.92
6.2
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
29
2.10
0.90
11.5
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
44
1.85
0.86
1.6
2.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
111
0.53
0.85
1.2
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
155
1426
1.24
0.85
7.5
6.8
u/l
75.8
75.7
0.00
144
1335
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
31
1.96
0.85
1.2
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
269
1.35
0.84
1.8
1.9
—
—
—
0
0
(3015736) pH of Urine
86
746
1.24
0.82
4.1
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
47
1.73
0.81
1.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
33
1.84
0.79
1.7
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
33
1.84
0.79
2.0
4.4
umol/l
35.5
35.3
—
6
28
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
48
1.69
0.79
1.1
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
52
427
1.28
0.79
4.4
3.2
kg/l
1.0
1.0
—
7
56
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
34
1.78
0.77
1.5
3.0
u/ml
11.3
40.3
—
6
34
(3052851) Hemolysis interference index of Serum or Plasma
9
54
1.69
0.75
3.7
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
60
505
1.25
0.74
2.9
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
38
1.87
0.74
1.7
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
25
2.02
0.73
1.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
25
2.02
0.73
1.2
1.3
—
—
—
0
0
(44790049)
5
26
1.94
0.71
1.8
1.5
—
—
—
0
0
(44790047)
5
26
1.94
0.71
1.8
1.5
—
—
—
0
0
(44806118)
5
26
1.94
0.71
1.8
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
26
1.94
0.71
1.4
1.5
—
—
—
0
0
(44790048)
5
26
1.94
0.71
1.8
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
58
1.57
0.70
1.1
1.4
mg/l
446.7
406.9
—
9
53
(1761868) Lipid panel - Serum or Plasma
65
752
0.82
0.70
2.6
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
51
425
1.25
0.69
1.8
1.8
mg/l
0.7
0.8
0.18
40
331
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
36
445
0.78
0.69
1.7
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
316
1.28
0.66
3.4
3.1
ng/l
532.6
290.1
0.20
23
213
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
28
1.80
0.66
2.0
2.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
113
1.45
0.63
1.7
2.4
u/l
373.2
849.1
—
6
42
(40768793) Breast Pathology biopsy report
8
50
1.62
0.62
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
173
1819
0.83
0.61
3.5
3.4
mmol/l
1.2
1.3
0.72
153
1701
(40768795) Lymph node Pathology biopsy report
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
21
0.00
0.60
0.0
3.4
—
65.9
—
0
21
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
43
508
0.81
0.56
1.4
1.4
g/l
1.9
2.1
0.50
32
299
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
159
0.68
0.56
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
335
0.78
0.54
1.4
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
62
1.47
0.53
1.2
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
39
1.55
0.53
5.2
6.3
—
768.6
—
0
7
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
83
1.47
0.53
2.0
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
20
153
1.33
0.52
1.5
2.2
g/l
10.3
10.0
0.11
20
139
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
332
0.79
0.51
1.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
47
1.50
0.48
1.7
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
147
1.32
0.47
4.6
4.6
%
1.0
0.9
—
5
46
(3023511) Choriogonadotropin [Units/volume] in Urine
5
81
0.61
0.46
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
14
103
1.38
0.46
1.8
2.7
ug/l
9.7
5.7
0.33
14
94
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
85
0.58
0.46
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
85
0.58
0.46
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
85
0.58
0.46
1.2
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
69
1.47
0.45
4.8
3.0
%
52.9
55.3
—
10
69
(3022313) Gas panel - Capillary blood
13
95
1.39
0.44
3.3
6.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
31
1.63
0.43
2.8
2.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
8
56
1.44
0.43
1.6
2.0
ug/l
142.7
196.2
—
8
48
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
183
1896
0.86
0.42
3.8
3.8
mmol/l
1.5
1.5
0.12
166
1775
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
86
787
1.14
0.42
2.5
2.4
nmol/l
71.3
74.5
0.59
80
717
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
26
214
1.24
0.41
2.6
2.4
%
27.1
24.7
0.25
21
187
(3005570) Glucose [Moles/volume] in Urine
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
3.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
123
1154
1.13
0.41
10.0
9.1
e9/l
4.5
4.0
1.62
108
1009
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
317
1.20
0.41
1.7
1.6
pmol/l
366.4
460.2
2.16
27
281
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
18
0.00
0.40
0.0
1.5
—
32.8
—
0
18
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
299
1.20
0.40
4.7
3.7
%
24.9
21.6
0.74
18
120
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
35
1.44
0.39
1.0
1.3
u/l
7.7
22.9
—
5
29
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
19
152
1.27
0.38
1.4
3.9
ug/l
2.5
9.6
1.50
14
118
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
112
0.70
0.38
2.8
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
116
1.31
0.38
3.5
6.2
mmol/l
1.7
1.3
—
9
92
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
69
1.32
0.37
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
49
546
0.87
0.34
1.5
1.4
u/ml
1.5
2.0
0.17
13
134
(42870588) Differential panel, method unspecified - Blood
70
641
1.13
0.34
7.8
5.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
90
0.66
0.33
1.8
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
15
120
1.27
0.31
3.5
6.0
kpa
5.0
5.1
0.20
15
114
(21494755) Public health laboratory ask at order entry panel
24
280
0.84
0.30
1.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
85
1.31
0.28
2.7
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
175
1697
1.11
0.28
3.9
4.7
mmol/mol
36.1
38.5
4.23
161
1607
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
538
0.89
0.28
1.5
1.6
—
—
—
0
0
(4034850)
8
64
1.26
0.27
6.4
7.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
66
1.22
0.27
1.0
1.1
—
18.0
—
0
11
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
67
1.20
0.26
1.9
2.5
%
158.8
169.1
—
8
67
(40768443) Skin Pathology biopsy report
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
138
0.79
0.26
1.2
1.3
—
35.8
—
0
10
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
160
1548
1.10
0.26
4.5
3.7
pmol/l
14.8
14.6
0.29
148
1417
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
186
1905
0.90
0.25
3.9
3.8
mmol/l
4.7
4.7
0.01
170
1794
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
137
0.79
0.25
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
81
0.73
0.24
1.5
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
218
2145
1.15
0.24
14.2
10.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
26
228
1.16
0.24
1.2
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
15
125
1.21
0.23
1.3
1.6
g/l
3.7
1.4
0.37
15
113
(4010399)
15
125
1.21
0.23
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
39
1.29
0.23
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
39
1.29
0.23
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
199
0.84
0.22
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
23
201
1.16
0.22
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
107
1.23
0.22
1.3
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
42
1.19
0.21
13.8
4.8
mmol/l
3.8
3.9
—
5
37
(1761482) Bacteria [#/volume] in Urine by Culture
5
42
1.19
0.21
2.8
3.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
7.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
10
0.00
0.21
0.0
39.7
—
135.7
—
0
10
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
8.9
—
0
10
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
852.8
—
0
12
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.8
—
0.6
—
0
12
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
1630.7
—
0
12
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
43
1.17
0.21
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
214.2
—
0
13
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
136
1.19
0.20
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
218
0.86
0.20
1.9
1.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
145
1407
1.08
0.19
2.9
3.0
u/l
36.5
42.4
0.69
140
1345
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
52
1.16
0.19
1.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
53
1.14
0.19
1.2
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
95
909
1.07
0.18
10.0
8.0
e9/l
0.0
0.0
0.50
77
733
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
5
66
0.75
0.17
1.2
1.9
g/l
1.3
1.5
—
5
58
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
196
1.13
0.17
2.9
3.8
%
33.6
31.6
0.41
17
129
(3028707) Methadone [Presence] in Urine by Screen method
8
68
1.18
0.17
1.8
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
199
1958
1.09
0.17
15.2
12.4
%
40.9
40.7
0.17
138
1591
(3020682) Albumin/Creatinine [Ratio] in Urine
41
441
0.92
0.16
3.2
3.9
mg/mmol
3.3
9.9
1.58
33
278
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
317
0.90
0.16
2.0
1.6
—
—
—
0
0
(3036489) Thrombin time
10
83
1.21
0.15
2.0
2.2
s
21.1
21.9
—
10
76
(3018010) Neutrophils/100 leukocytes in Blood
92
956
0.94
0.15
5.7
5.6
%
60.7
56.0
2.84
86
913
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
93
1.19
0.15
1.1
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
89
0.78
0.14
1.3
2.1
u/l
34.1
41.3
—
7
81
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
216
2135
1.10
0.14
9.8
8.9
u/l
22.6
27.2
4.72
205
2067
(3027944) Amphetamines [Presence] in Urine
14
160
0.87
0.14
2.3
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
84
1.20
0.14
1.6
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
159
0.87
0.13
2.4
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
159
0.87
0.13
2.3
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
159
0.87
0.13
2.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
11
94
1.18
0.13
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
16
142
1.14
0.13
2.7
4.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
183
1802
1.06
0.12
14.6
10.1
ml/min/173m2
96.9
90.2
2.74
160
1430
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
190
1926
0.94
0.12
4.2
4.2
mmol/l
2.9
2.8
0.44
172
1799
(3041096) Erythrocytes [Presence] in Urine by Automated
57
544
1.06
0.12
2.6
2.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
211
1.10
0.11
2.8
2.5
ug/l
0.8
0.6
0.59
16
120
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
382
0.93
0.11
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
146
0.88
0.10
1.8
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
231
2296
1.11
0.08
21.8
16.7
e9/l
258.0
255.7
0.22
223
2242
(3011288) Drugs identified in Urine by Screen method
10
113
0.88
0.08
2.8
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
65
0.76
0.08
1.8
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
64
620
1.04
0.08
1.7
1.8
pmol/l
92.6
95.9
0.22
38
321
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
68
1.03
0.08
1.7
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
41
428
0.95
0.08
2.1
2.7
umol/l
341.6
5331.8
1.78
34
377
(3000330) Specific gravity of Urine by Test strip
6
72
0.83
0.07
4.7
2.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
75
0.80
0.07
1.3
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
111
0.90
0.06
2.1
2.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
143
1412
1.03
0.06
3.3
3.8
mm/h
11.3
9.5
0.66
131
1315
(3024731) MCV [Entitic volume]
231
2299
1.09
0.05
21.8
16.6
fl
88.4
90.1
7.13
226
2266
(36660697) Celiac disease serology panel - Serum
22
209
1.06
0.04
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
231
2300
1.08
0.04
21.9
16.6
e12/l
4.6
4.6
1.44
223
2241
(3035941) MCH [Entitic mass]
231
2300
1.08
0.04
21.8
16.5
pg
29.6
30.1
4.17
226
2267
(40760892) CBC W Ordered Manual Differential panel - Blood
49
477
1.03
0.04
3.7
4.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
231
0.95
0.04
1.9
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
16
170
0.94
0.04
3.9
3.6
u/l
206.8
229.7
0.46
16
164
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
202
2032
0.97
0.04
14.1
11.5
mg/l
25.5
22.0
0.60
160
1516
(3001604) Monocytes [#/volume] in Blood
98
994
0.98
0.04
5.9
5.5
e9/l
0.6
0.6
2.73
85
876
(3010813) Leukocytes [#/volume] in Blood
231
2301
1.07
0.03
22.0
16.7
e9/l
7.0
6.6
2.27
222
2243
(3022096) Basophils/100 leukocytes in Blood
92
908
1.02
0.03
6.4
5.7
%
0.7
0.7
0.02
86
861
(3000963) Hemoglobin [Mass/volume] in Blood
231
2302
1.07
0.02
22.0
16.8
g/l
136.9
136.9
0.02
226
2267
(3012516) Albumin [Mass/volume] in Urine
41
419
0.97
0.02
2.5
3.2
mg/l
1072.4
66.0
0.46
31
267
(3027945) Reticulocytes/100 erythrocytes in Blood
16
167
0.96
0.01
2.8
2.9
%
1.5
1.7
0.47
16
153
(3006504) Eosinophils/100 leukocytes in Blood
93
938
0.99
0.01
6.4
5.6
%
2.6
2.8
0.46
88
888
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
52
513
1.02
0.01
1.5
1.6
mmol/l
1.3
1.4
0.60
47
437
(3019069) Monocytes/100 leukocytes in Blood
95
943
1.01
0.01
6.4
5.9
%
9.6
8.3
2.89
90
899
(3013115) Eosinophils [#/volume] in Blood
103
1023
1.01
0.01
6.1
6.0
e9/l
0.2
0.2
0.28
90
915
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
126
0.95
0.00
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
194
1.03
0.00
1.6
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
194
1.03
0.00
1.9
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
100
994
1.01
0.00
5.9
5.5
e9/l
0.0
0.0
0.72
86
877
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
182
1824
0.99
0.00
3.8
3.8
mmol/l
5.5
5.8
4.01
164
1694
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
184
1839
1.00
0.00
5.1
4.4
mu/l
1.8
1.8
0.17
169
1712
(3002030) Lymphocytes/100 leukocytes in Blood
97
972
1.00
0.00
6.2
5.7
%
24.3
29.6
4.33
92
925
(40761535) Cells panel - Urine sediment
13
133
0.98
0.00
4.3
3.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
126
1.03
0.00
1.4
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
26
256
1.02
0.00
1.9
1.6
nmol/l
928.0
1180.7
0.99
20
193
(3019198) Lymphocytes [#/volume] in Blood
102
1023
0.99
0.00
5.8
5.6
e9/l
1.7
1.9
1.45
89
918
(3003694) ABO and Rh group [Type] in Blood
59
595
0.99
0.00
1.4
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
70
1.00
0.00
1.1
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
68
0.88
0.00
2.8
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
9.9
—
0
7
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
168.6
—
0
7
(4211845)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
98
0.92
0.00
1.9
1.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
50
1.00
0.00
1.4
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
4.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.9
—
182.0
—
0
8
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
83.2
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
99.3
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.4
—
0
5
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
8.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
8.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
8.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_NEUROFIBROMATOSIS_1 – Neurofibromatosis, type 1
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).